首页 社会内容详情
game bài kiếm tiền(www.84vng.com):MClean to acquire 60% equity interest in JCS Biotech

game bài kiếm tiền(www.84vng.com):MClean to acquire 60% equity interest in JCS Biotech

分类:社会

标签: # 环球国际娱乐网址多少

网址:

SEO查询: 爱站网 站长工具

点击直达

皇冠正网平台出租www.hg108.vip)是皇冠(正网)接入菜宝钱包的TRC20-USDT支付系统,为皇冠代理提供专业的网上运营管理系统。系统实现注册、充值、提现、客服等全自动化功能。采用的USDT匿名支付、阅后即焚的IM客服系统,让皇冠代理的运营更轻松更安全。

PETALING JAYA: MClean Technologies Bhd wholly-owned subsidiary MClean Precision Pte Ltd has proposed to acquire 60% equity interest in JCS Biotech Pte Ltd in Singapore from its vendors for a total purchase consideration of RM135mil.

In a filing with Bursa Malaysia yesterday, MClean noted the RM135mil consideration will be satisfied via a combination of RM18mil in cash, issuance of about 329.32 million new MClean shares at an issue price of 22 sen each, which is equivalent to RM72.45mil, and the issuance of 202.5 million irredeemable convertible preference shares in MClean at an issue price of 22 sen each, equivalent to RM44.55mil.

The proposed acquisition is a related party transaction by virtue of Yeo Hock Huat being a director and major shareholder in both MClean and JCS Biotech.

“At this juncture, Yeo, the beneficial owner of the remaining 40% of JCS Biotech shares, through his direct and indirect equity interest in JCS Biotech, does not intend to dispose of the remaining 40% of JCS Biotech shares,” MClean said.

,

game bài kiếm tiền(www.84vng.com):game bài kiếm tiền(www.84vng.com) cổng Chơi tài xỉu uy tín nhất việt nam。game bài kiếm tiền(www.84vng.com)game tài Xỉu game bài kiếm tiền online công bằng nhất,game bài kiếm tiền(www.84vng.com)cổng game không thể dự đoán can thiệp,mở thưởng bằng blockchain ,đảm bảo kết quả công bằng.

,

Meanwhile, MClean does not intend to acquire the balance 40% JCS Biotech shares because, with proposed acquisition of 60% of equity interest in JCS Biotech, MClean is already in control of JCS Biotech and is able to consolidate the results of JCS Biotech in MClean and its subsidiaries.

Additionally, it is beneficial for JCS Biotech to maintain at least 30% ownership directly or indirectly by a Singaporean shareholder, namely Yeo, in order for JCS Biotech to continue to be qualified for various benefits, including grants, from Enterprise Singapore, a Singaporean government agency which champions enterprise growth.

“This continual affiliation with Enterprise Singapore augurs well for JCS Biotech as products manufactured in Singapore with the “Made in Singapore” branding is deemed as desirable particularly by JCS Biotech’s customers,” it said.

The proposed acquisition will result in a “significant change in the business direction or policy” of MClean and its subsidiaries.


转载说明:本文转载自Sunbet。,

欧博会员登录www.aLLbet8.vip)是欧博集团的官方网站。欧博会员登录开放Allbet注册、Allbe代理、Allbet电脑客户端、Allbet手机版下载等业务。

  • 空气传播爱 @回复Ta

    2022-11-30 00:11:24 

      思量{liang}到新加坡当前疫情形势,使馆再次提醒【xing】,疫情时代跨境旅行风险高,海内拟来新职员应坚持“非需要“yao”、非紧要、不旅行”,审慎做出出行决‘jue’议。确需出行的,应提前领会收支境政策『ce』并备齐相关质料,选择直航出行。旅行时代增强防疫意识,全程做好小我私人防护,入境后做好防疫措施。如在海内接种疫苗,应在完成所有剂次接种14天后再出『chu』国。此外,还应思量到【dao】可能发生的熏染、收支境受阻和滞留风险,做{zuo}美【mei】意理和{he}经济上的《de》准备。这写的也太好了。

发布评论